This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Xerophthalmia

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Xerophthalmia is a major cause of blindness in children in Africa and Latin America.

  • peak incidence is 3-5 years of age
  • associated with vitamin A deficiency and malnutrition in general

Clinical features:

  • night blindness is an early manifestation. Later, there is drying - xerosis - of the conjunctiva with the development of characteristic oval or triangular spots - Bitot's spots
  • xerosis of the cornea is seen initially as a mild haziness inferiorly. This is followed by corneal ulceration with full thickness dissolution known as keratomalacia - there may be extrusion of the intraocular contents

Treatment:

  • vitamin A therapy and a protein-rich diet are essential.
  • topical antibiotics are given to prevent secondary bacterial infection. Keratomalacia is irreversible and causes permanent corneal scarring

Diet supplements rich in vitamin A or beta-carotene should be provided in high risk areas to prevent the condition (NB vitamin A should be avoided during pregnancy because of the risk of vitamin A embryopathy).


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.